• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾上腺皮质癌的切除策略]

[Resection strategies for adrenocortical carcinoma].

作者信息

Schimmack S, Strobel O

机构信息

Klinik für Allgemein‑, Viszeral und Transplantationschirurgie, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland.

出版信息

Chirurg. 2019 Jan;90(1):9-14. doi: 10.1007/s00104-018-0712-4.

DOI:10.1007/s00104-018-0712-4
PMID:30159583
Abstract

Adrenocortical carcinomas (ACC) are rare and aggressive neoplasms. Due to their high rate of local recurrence and distant metastases (up to 85%) they are associated with a poor survival. The 5‑year survival in ACC patients with lymph node metastasis or local infiltration is 50% and with distant metastasis less than 15%. An R0 resection with locoregional and para-aortic/paracaval lymphadenectomy is the only curative option and reasonable treatment possibility. The treatment of these patients should therefore be planned and carried out in centers. Local recurrences and distant metastases should also be treated with R0 resection when feasible, combined with neoadjuvant/adjuvant chemotherapy and/or radiation. In the case of an asymptomatic non-resectable ACC, debulking operations cannot be recommended. The primary operation can also be done in a minimally invasive procedure if principles of oncological surgery are followed (radical resection, no damage of the tumor capsule, lymphadenectomy), since survival after open and minimally invasive laparoscopic resection was comparable. Palliative resections are only indicated in symptomatic patients.

摘要

肾上腺皮质癌(ACC)是罕见的侵袭性肿瘤。由于其局部复发和远处转移率高(高达85%),其生存率较低。伴有淋巴结转移或局部浸润的ACC患者5年生存率为50%,伴有远处转移的患者5年生存率低于15%。行R0切除并进行局部及主动脉旁/腔静脉旁淋巴结清扫是唯一的治愈性选择和合理的治疗方案。因此,这些患者的治疗应在专科中心进行规划和实施。对于局部复发和远处转移,可行时也应行R0切除,并联合新辅助/辅助化疗和/或放疗。对于无症状的不可切除ACC,不建议行减瘤手术。如果遵循肿瘤外科手术原则(根治性切除、不损伤肿瘤包膜、淋巴结清扫),原发性手术也可采用微创手术,因为开放手术和微创腹腔镜切除后的生存率相当。姑息性切除仅适用于有症状的患者。

相似文献

1
[Resection strategies for adrenocortical carcinoma].[肾上腺皮质癌的切除策略]
Chirurg. 2019 Jan;90(1):9-14. doi: 10.1007/s00104-018-0712-4.
2
[Surgical strategies for non-metastatic adrenocortical carcinoma].[非转移性肾上腺皮质癌的手术策略]
Chirurg. 2018 Jun;89(6):434-439. doi: 10.1007/s00104-017-0582-1.
3
Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.成人局限性/局部进展期原发性肾上腺皮质癌(ENSAT I - III期)的腹腔镜与开放性肾上腺切除术:无瘤切缘是决定手术结果的关键因素吗?文献综述
J Laparoendosc Adv Surg Tech A. 2018 Apr;28(4):408-414. doi: 10.1089/lap.2017.0546. Epub 2018 Jan 10.
4
Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group.肾上腺皮质癌的评估、分期和外科治疗:SSO 内分泌和头颈部疾病部位工作组的更新。
Ann Surg Oncol. 2018 Nov;25(12):3460-3468. doi: 10.1245/s10434-018-6749-2. Epub 2018 Sep 18.
5
Minimally invasive adrenal surgery: virtue or vice?微创肾上腺手术:是福还是祸?
Future Oncol. 2018 Feb;14(3):267-276. doi: 10.2217/fon-2017-0420. Epub 2018 Jan 18.
6
Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.肾上腺皮质癌的根治性切除:术后复发率及模式
Ann Surg Oncol. 2016 Jan;23(1):126-33. doi: 10.1245/s10434-015-4810-y. Epub 2015 Aug 18.
7
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.肾上腺皮质癌淋巴结复发模式:对原发性手术治疗的可能影响。
Ann Surg Oncol. 2019 Feb;26(2):531-538. doi: 10.1245/s10434-018-6999-z. Epub 2018 Nov 15.
8
Recommendation for standardized surgical management of primary adrenocortical carcinoma.原发性肾上腺皮质癌的标准化手术治疗建议。
Surgery. 2012 Jul;152(1):123-32. doi: 10.1016/j.surg.2011.09.030. Epub 2012 Feb 4.
9
Adrenocortical carcinoma surgery-surgical extent and approach.肾上腺皮质癌手术——手术范围及入路
Langenbecks Arch Surg. 2016 Nov;401(7):991-997. doi: 10.1007/s00423-016-1462-8. Epub 2016 Jul 13.
10
Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.淋巴结清扫术对肾上腺皮质癌患者肿瘤学结局的影响。
Ann Surg. 2012 Feb;255(2):363-9. doi: 10.1097/SLA.0b013e3182367ac3.

引用本文的文献

1
Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma.血浆纤维蛋白原在肾上腺皮质癌患者中的诊断及复发预测价值
Clin Med Insights Oncol. 2025 Jan 7;19:11795549241271657. doi: 10.1177/11795549241271657. eCollection 2025.
2
Prognostic value of fibrinogen change value in adrenocortical carcinoma patients.纤维蛋白原变化值在肾上腺皮质癌患者中的预后价值
Discov Oncol. 2024 Jul 30;15(1):320. doi: 10.1007/s12672-024-01197-5.
3
Multidisciplinary team therapy for left giant adrenocortical carcinoma: A case report.

本文引用的文献

1
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database.肾上腺皮质癌生存预测因素分析:来自国家癌症数据库的研究。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3566-3573. doi: 10.1210/jc.2018-00918.
2
The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study.肾上腺皮质癌的特征与趋势:一项基于美国人群的研究
J Clin Med Res. 2018 Aug;10(8):636-640. doi: 10.14740/jocmr3503w. Epub 2018 Jun 27.
3
Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.
左肾上腺巨大皮质癌的多学科团队治疗:一例报告。
World J Clin Cases. 2021 Jul 16;9(20):5737-5743. doi: 10.12998/wjcc.v9.i20.5737.
4
SIRT6 abrogation promotes adrenocortical carcinoma through activation of NF-κB signaling.SIRT6 缺失通过激活 NF-κB 信号促进肾上腺皮质癌的发生。
Mol Cell Biochem. 2019 Aug;458(1-2):1-10. doi: 10.1007/s11010-019-03525-8. Epub 2019 Apr 15.
成人局限性/局部进展期原发性肾上腺皮质癌(ENSAT I - III期)的腹腔镜与开放性肾上腺切除术:无瘤切缘是决定手术结果的关键因素吗?文献综述
J Laparoendosc Adv Surg Tech A. 2018 Apr;28(4):408-414. doi: 10.1089/lap.2017.0546. Epub 2018 Jan 10.
4
[Surgical strategies for non-metastatic adrenocortical carcinoma].[非转移性肾上腺皮质癌的手术策略]
Chirurg. 2018 Jun;89(6):434-439. doi: 10.1007/s00104-017-0582-1.
5
Surgical Management of Adrenocortical Carcinoma: Impact of Laparoscopic Approach, Lymphadenectomy, and Surgical Volume on Outcomes-A Systematic Review and Meta-analysis of the Current Literature.肾上腺皮质癌的外科治疗:腹腔镜手术入路、淋巴结清扫术及手术量对预后的影响——当前文献的系统评价和荟萃分析
Eur Urol Focus. 2016 Feb;1(3):241-250. doi: 10.1016/j.euf.2015.12.001. Epub 2015 Dec 24.
6
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma.欧洲内分泌外科医师学会(ESES)和欧洲肾上腺肿瘤研究网络(ENSAT)关于肾上腺皮质癌手术治疗的建议。
Br J Surg. 2017 Mar;104(4):358-376. doi: 10.1002/bjs.10414.
7
Adrenocortical carcinoma with inferior vena cava tumor thrombus.肾上腺皮质癌伴下腔静脉瘤栓
Surgery. 2017 Jan;161(1):240-248. doi: 10.1016/j.surg.2016.07.040. Epub 2016 Nov 17.
8
Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?肾上腺皮质癌的淋巴结清扫术:是否具有治疗益处?
Ann Surg Oncol. 2016 Dec;23(Suppl 5):708-713. doi: 10.1245/s10434-016-5536-1. Epub 2016 Sep 2.
9
Surgical quality of minimally invasive adrenalectomy for adrenocortical carcinoma: a contemporary analysis using the National Cancer Database.肾上腺皮质癌微创肾上腺切除术的手术质量:使用国家癌症数据库的当代分析
BJU Int. 2017 Mar;119(3):436-443. doi: 10.1111/bju.13618. Epub 2016 Sep 1.
10
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.肾上腺偶发瘤的管理:欧洲内分泌学会临床实践指南与欧洲肾上腺肿瘤研究网络合作制定
Eur J Endocrinol. 2016 Aug;175(2):G1-G34. doi: 10.1530/EJE-16-0467.